MedPath
HSA Approval

AMOXAPEN 500 CAPSULE 500 mg

SIN01943P

AMOXAPEN 500 CAPSULE 500 mg

AMOXAPEN 500 CAPSULE 500 mg

June 23, 1988

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

J01CA04

amoxicillin

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

REMEDICA LTD

Active Ingredients

AMOXYCILLIN TRIHYDRATE EQV AMOXYCILLIN

500 mg

Amoxicillin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AMOXAPEN 500 CAPSULE 500 mg - HSA Approval | MedPath